CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- PositionGross margin is 16.9%, lower than 95% of its Medical Devices peers (median 61.5%)
- FinancialsAltman Z-Score 2.52: grey zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.88BCNY280.09M · vs all stocks (USD)
Revenue (TTM)
728.92MCNY108.77M · vs all stocks (USD)
Profit Margin
-1.73%vs Medical Devices peers
Beta
0.7340xvs all stocks
52-Week Change
-8.70%vs all stocks
Market Capitalization
1.88BCNY280.09M · vs all stocks (USD)
Enterprise Value
1.38BCNY205.61M · vs all stocks (USD)
Price to Sales (TTM)
2.58xvs Medical Devices peers
Price to Book (MRQ)
1.49xvs Medical Devices peers
Enterprise to Revenue
1.89xvs Medical Devices peers
Enterprise to EBITDA
-79.72xvs Medical Devices peers
Gross Margin
16.91%vs Medical Devices peers
Profit Margin
-1.73%vs Medical Devices peers
Operating Margin
-10.90%vs Medical Devices peers
Return on Assets (TTM)
-0.80%vs Medical Devices peers
Return on Equity (TTM)
-1.31%vs Medical Devices peers
Revenue (TTM)
728.92MCNY108.77M · vs all stocks (USD)
Revenue per Share (TTM)
7.59CNYUpdated Sep 21, 2026Quarterly Revenue Growth
-7.80%vs Medical Devices peers
Gross Profit (TTM)
143.90MCNY21.47M · vs all stocks (USD)
EBITDA (TTM)
80.87MCNY12.07M · vs all stocks (USD)
Net Income (TTM)
-12.59MCNY-1.88M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
814.37%vs Medical Devices peers
Operating Cash Flow (TTM)
-17.17MCNY-2.56M · vs all stocks (USD)
Payout Ratio
698.71%vs Medical Devices peers
Minority Interest (Equity)
-1.53MCNYFY2025 · Dec 31, 2025Revenue
721.61MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
558.12MCNYFY2025 · Dec 31, 2025Gross Profit
163.50MCNYFY2025 · Dec 31, 2025Operating Income
61.17MCNY9.13M · vs all stocks (USD)
Pre-tax Income
-8.70MCNYFY2025 · Dec 31, 2025Income Tax Expense
-3.52MCNYFY2025 · Dec 31, 2025Net Income
-5.18MCNYFY2025 · Dec 31, 2025EBIT
-2.35MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
80.87MCNYFY2025 · Dec 31, 2025Research & Development
25.99MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
33.36MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.40MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
6.30MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
6.35MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0274CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0274CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
96.54MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
96.54MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-5.18MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
2.53MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-225.55MCNYFY2025 · Dec 31, 2025Free Cash Flow
-249.65MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
181.61MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-5.18MCNYFY2025 · Dec 31, 2025Other Non-cash Items
1.97MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-130.78MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-91.56MCNYFY2025 · Dec 31, 2025Capital Expenditures
-24.09MCNYFY2025 · Dec 31, 2025Purchase of Investments
-659.25MCNYFY2025 · Dec 31, 2025Sale of Investments
326.00MCNYFY2025 · Dec 31, 2025Other Investing Activity
3.63MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-353.72MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
256.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-171.50MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-18.66MCNYFY2025 · Dec 31, 2025Other Financing Charges
-95.27MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-29.43MCNYFY2025 · Dec 31, 2025Shares Outstanding
100.00MSharesUpdated Sep 21, 2026Float Shares
49.22MSharesUpdated Sep 21, 2026% Held by Insiders
55.52%vs all stocks
% Held by Institutions
4.46%vs all stocks
Total Cash (MRQ)
767.48MCNY114.52M · vs all stocks (USD)
Total Cash per Share (MRQ)
7.99CNYUpdated Sep 21, 2026Total Debt (MRQ)
344.85MCNY51.46M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2859xvs Medical Devices peers
Current Ratio (MRQ)
2.40xvs Medical Devices peers
Book Value per Share (MRQ)
12.58CNYUpdated Sep 21, 2026Total Assets
2.06BCNY308.06M · vs all stocks (USD)
Total Current Assets
1.79BCNYFY2025 · Dec 31, 2025Total Liabilities
841.14MCNYFY2025 · Dec 31, 2025Total Non-current Assets
277.58MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
73.43MCNYFY2025 · Dec 31, 2025Total Current Liabilities
767.71MCNYFY2025 · Dec 31, 2025Cash
184.20MCNYFY2025 · Dec 31, 2025Cash Equivalents
514.15MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
698.35MCNYFY2025 · Dec 31, 2025Accounts Receivable
759.83MCNYFY2025 · Dec 31, 2025Inventory
280.78MCNYFY2025 · Dec 31, 2025Accounts Payable
323.07MCNYFY2025 · Dec 31, 2025Short-term Debt
205.53MCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.01MCNYFY2025 · Dec 31, 2025Long-term Debt
42.46MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
17.22MCNYFY2025 · Dec 31, 2025Common Stock (Book)
100.00MCNYFY2025 · Dec 31, 2025Retained Earnings
353.19MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.22BCNY182.55M · vs all stocks (USD)
Treasury Stock
73.14MCNYFY2025 · Dec 31, 202552-Week Low
15.16CNYUpdated Sep 21, 202652-Week High
27.40CNYUpdated Sep 21, 202652-Week Change
-8.70%vs all stocks
Beta
0.7340xvs all stocks
50-Day MA
18.46CNYUpdated Sep 21, 2026200-Day MA
21.55CNYUpdated Sep 21, 2026Avg 10-Day Volume
1.13MSharesUpdated Sep 21, 2026Avg 30-Day Volume
1.28MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
-0.1300CNYUpdated Sep 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 16.9%, lower than 95% of its Medical Devices peers (median 61.5%)Significant
Gross margin: 0.17Industry median: 0.62Industry P5: 0.27Peers compared: 102
Financial Health
Altman Z-Score 2.52: grey zoneSignificant
Altman Z-Score: 2.52
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Elite Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Tiansheng Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Abclon Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Guangdong Jiaying Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Immuneering Corporation
Tier 1ProductionApproval-Gated PipelineRule
Rocket Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Invivyd Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Cresco Labs Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
Fulcrum Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Santhera Pharmaceuticals Holding AG
Tier 1ProductionApproval-Gated PipelineRuleRisk